The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

Lewy body diseases (LBDs) are a class of debilitating neurodegenerative disorders linked to the abnormal aggregation of the ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Deep brain stimulation (DBS ... and were not triggered by the local field potentials. Eight patients with advanced Parkinson’s disease were included in the study, and all underwent DBS ...

Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May 28, 2024 — Regular high caffeine consumption affects dopamine function in patients with Parkinson's disease ...

Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...

A passionate rave and prog rock fan with Parkinson's disease who teamed up with a composer ... other collaborations created with Parkinson's patients at a concert arranged by the the RNCM.

Symptoms of essential tremor (ET) are similar to those of Parkinson’s disease ... parts of the brain associated with PD and with ET. To determine the compensatory and/or degenerative anatomical ...

We aimed to evaluate microscale changes in the bilateral red nucleus and substantia nigra of patients ... Unified Parkinson's Disease Rating Scale (UPDRS III) scores. Early diagnosis of PD using ...

Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.